Patents Assigned to TRUETIVA, Inc.
  • Publication number: 20240041792
    Abstract: The present invention relates to a topical composition comprising a cannabinoid, extracellular matrix component or extracellular matrix fragment, and a pharmaceutically acceptable carrier, excipient, diluent, reagent, or combinations thereof, and use thereof in the treatment skin disorders, muscle pain, and arthritic pain.
    Type: Application
    Filed: July 26, 2023
    Publication date: February 8, 2024
    Applicant: TRUETIVA, Inc.
    Inventor: J. Phillip KENNEDY
  • Publication number: 20230277477
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, cannabidiol isomer, or cannabidiol analog and combinations thereof for treating dermatological disease, and methods for treating dermatological diseases by administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the skin of a patient in need of treatment.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 7, 2023
    Applicant: TRUETIVA, Inc.
    Inventor: J. Phillip KENNEDY
  • Publication number: 20230270690
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, cannabidiol isomer, or cannabidiol analog and combinations thereof for treating dermatological disease, and methods for treating dermatological diseases by administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the skin of a patient in need of treatment.
    Type: Application
    Filed: May 9, 2023
    Publication date: August 31, 2023
    Applicant: TRUETIVA, Inc.
    Inventor: J. Phillip KENNEDY
  • Patent number: 11337905
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, or cannabidiol analog for lightening or whitening skin, and methods for lightening skin tone or whitening skin by administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the skin.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: May 24, 2022
    Assignee: Truetiva, Inc.
    Inventor: J. Phillip Kennedy
  • Publication number: 20220117990
    Abstract: Compounds capable of binding to and inhibiting the activity of RAS protein are described herein along with compositions and methods useful for treating RAS protein related diseases such as, for example, cancer.
    Type: Application
    Filed: September 29, 2021
    Publication date: April 21, 2022
    Applicant: Truetiva, Inc.
    Inventor: J. Phillip Kennedy
  • Publication number: 20210015762
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoids and bioenhancers for treating obesity, eating disorders, metabolic disorders, and other body weight related diseases and disorders, and methods for treating obesity, eating disorders, metabolic disorders, and other body weight related diseases and disorders by administering compositions containing cannabinoid and a bioenhancer.
    Type: Application
    Filed: July 16, 2020
    Publication date: January 21, 2021
    Applicant: Truetiva, Inc.
    Inventor: J. Phillip KENNEDY
  • Publication number: 20200009077
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, cannabidiol isomer, or cannabidiol analog and combinations thereof for treating dermatological disease, and methods for treating dermatological diseases by administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the skin of a patient in need of treatment.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 9, 2020
    Applicant: TRUETIVA, Inc.
    Inventor: J. Phillip KENNEDY
  • Publication number: 20200009078
    Abstract: Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, cannabidiol isomer, or cannabidiol analog and combinations thereof for treating dermatological disease, and methods for treating dermatological diseases by administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the skin of a patient in need of treatment.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 9, 2020
    Applicant: TRUETIVA, Inc.
    Inventor: J. Phillip KENNEDY